Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194219 | Category: Medical Devices & Consumables | Pages: 63 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics. This report contains market size and forecasts of Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics in global, including the following market information:
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Imaging Techniques Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics include Allergan plc, Pfizer Inc, Gilead Sciences, Genfit SA, Novartis AG, Intercepts Pharmaceuticals, Cadila Healthcare, Novo Nordisk and Raptor Pharmaceutical Corp, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Segment Percentages, by Type, 2022 (%)
    Imaging Techniques
    Diagnostic Tests
    Biopsy
    Others
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Segment Percentages, by Application, 2022 (%)
    Hospital Pharmacy
    Online Channels
    Retail Channels
    Others
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Allergan plc
    Pfizer Inc
    Gilead Sciences
    Genfit SA
    Novartis AG
    Intercepts Pharmaceuticals
    Cadila Healthcare
    Novo Nordisk
    Raptor Pharmaceutical Corp
    Galmed Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics, market overview.
Chapter 2: Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Overall Market Size
    2.1 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size: 2022 VS 2029
    2.2 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Players in Global Market
    3.2 Top Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies Ranked by Revenue
    3.3 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size Markets, 2022 & 2029
        4.1.2 Imaging Techniques
        4.1.3 Diagnostic Tests
        4.1.4 Biopsy
        4.1.5 Others
    4.2 By Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2023
        4.2.2 By Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2024-2029
        4.2.3 By Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2022 & 2029
        5.1.2 Hospital Pharmacy
        5.1.3 Online Channels
        5.1.4 Retail Channels
        5.1.5 Others
    5.2 By Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2023
        5.2.2 By Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2024-2029
        5.2.3 By Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2022 & 2029
    6.2 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2023
        6.2.2 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2024-2029
        6.2.3 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2029
        6.3.2 US Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.3.3 Canada Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.3.4 Mexico Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2029
        6.4.2 Germany Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.4.3 France Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.4.4 U.K. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.4.5 Italy Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.4.6 Russia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.4.7 Nordic Countries Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.4.8 Benelux Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2029
        6.5.2 China Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.5.3 Japan Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.5.4 South Korea Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.5.5 Southeast Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.5.6 India Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2029
        6.6.2 Brazil Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.6.3 Argentina Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2018-2029
        6.7.2 Turkey Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.7.3 Israel Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.7.4 Saudi Arabia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
        6.7.5 UAE Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2018-2029
7 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies Profiles
    7.1 Allergan plc
        7.1.1 Allergan plc Company Summary
        7.1.2 Allergan plc Business Overview
        7.1.3 Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.1.4 Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.1.5 Allergan plc Key News & Latest Developments
    7.2 Pfizer Inc
        7.2.1 Pfizer Inc Company Summary
        7.2.2 Pfizer Inc Business Overview
        7.2.3 Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.2.4 Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.2.5 Pfizer Inc Key News & Latest Developments
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Company Summary
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.3.4 Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.3.5 Gilead Sciences Key News & Latest Developments
    7.4 Genfit SA
        7.4.1 Genfit SA Company Summary
        7.4.2 Genfit SA Business Overview
        7.4.3 Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.4.4 Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.4.5 Genfit SA Key News & Latest Developments
    7.5 Novartis AG
        7.5.1 Novartis AG Company Summary
        7.5.2 Novartis AG Business Overview
        7.5.3 Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.5.4 Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.5.5 Novartis AG Key News & Latest Developments
    7.6 Intercepts Pharmaceuticals
        7.6.1 Intercepts Pharmaceuticals Company Summary
        7.6.2 Intercepts Pharmaceuticals Business Overview
        7.6.3 Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.6.4 Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.6.5 Intercepts Pharmaceuticals Key News & Latest Developments
    7.7 Cadila Healthcare
        7.7.1 Cadila Healthcare Company Summary
        7.7.2 Cadila Healthcare Business Overview
        7.7.3 Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.7.4 Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.7.5 Cadila Healthcare Key News & Latest Developments
    7.8 Novo Nordisk
        7.8.1 Novo Nordisk Company Summary
        7.8.2 Novo Nordisk Business Overview
        7.8.3 Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.8.4 Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.8.5 Novo Nordisk Key News & Latest Developments
    7.9 Raptor Pharmaceutical Corp
        7.9.1 Raptor Pharmaceutical Corp Company Summary
        7.9.2 Raptor Pharmaceutical Corp Business Overview
        7.9.3 Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.9.4 Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.9.5 Raptor Pharmaceutical Corp Key News & Latest Developments
    7.10 Galmed Pharmaceuticals
        7.10.1 Galmed Pharmaceuticals Company Summary
        7.10.2 Galmed Pharmaceuticals Business Overview
        7.10.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
        7.10.4 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
        7.10.5 Galmed Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?